Scarica l'app Stockscreener
63.36
0.40%
-0.239
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché BMY Giù?
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Bristol Myers Squibb Co Borsa (BMY) Ultime notizie
Baird Financial Group Inc. Cuts Holdings in Bristol Myers Squibb Company $BMY - MarketBeat
Why is Bristol Myers Squibb (NYSE:BMY) stock in focus today? - Kalkine Media
Bristol Myers Squibb (BMY) Faces Fresh Patent Pressure In Cardiac Drug Fight - simplywall.st
Bristol Myers Squibb awarded honour for being first employer to gain triple-region Menopause Friendly Accreditation - hrnews.co.uk
Bristol-Myers Squibb stock heads into the open after a 1.0 percent dip - ad-hoc-news.de
Bristol-Myers Squibb Co (BMY) Insider Sale: EVP, Chief Medical O - GuruFocus
Multiple Myeloma Market Poised for Sustained Growth Amid Advancements in Treatment and Clinical Innovation by 2036 – DelveInsight | Regeneron, Sanofi, Arcellx, Gilead, AbbVie, Bristol-Myers Squibb - Barchart.com
BMY Gains 19.4% Year to Date: Should You Buy, Sell or Hold the Stock? - TradingView
Core Capital Management & Research inc. Invests $4.73 Million in Bristol Myers Squibb Company $BMY - MarketBeat
Bristol-Myers Squibb (NYSE:BMY) Passes the Dividend Screen, but Payout Sustainability Is the Key Question - ChartMill
Allworth Financial LP Sells 91,375 Shares of Bristol Myers Squibb Company $BMY - MarketBeat
Bristol Myers Squibb stock heads into the open after a 3.2 percent drop - ad-hoc-news.de
Bristol-Myers Squibb stock heads into the open after a 3.2 percent drop - ad-hoc-news.de
Will The Recent Pipeline Progress Boost BMY's Portfolio Expansion? - Zacks Investment Research
What macro factors could move Bristol Myers Squibb (NYSE:BMY) shares this week? - Kalkine Media
National Coalition of Pharmaceutical Industry, Academic, and Nonprofit Partners Launches Fifth Winn CIPP Cohort - Finviz
Bristol Myers Squibb Company $BMY Shares Purchased by Waverly Advisors LLC - MarketBeat
CD&R Taps Former Bristol-Myers CEO Caforio in Healthcare Push - Bloomberg.com
Bristol Myers (NYSE: BMY) insider unloads 6,249 shares - Stock Titan
Bristol-Myers Squibb stock heads into the open after a 3.2% drop - ad-hoc-news.de
Bristol-Myers Squibb Co (BMY) Shares Fall 3.2% -- What GF Score of 71 Tells Investors - GuruFocus
Bristol Myers Squibb Co. stock underperforms Tuesday when compared to competitors - MarketWatch
Bristol-Myers Squibb Co Stock (BMY) Moved Down by 3.25% on Sep 8: Facts Behind the Movement - TradingKey
Bristol Myers' blood cancer cell therapy succeeds in mid-stage trial | Business Information & News | FE - Westlaw Today
What's Going On With Bristol Myers Stock Today?Bristol-Myers Squibb (NYSE:BMY) - Benzinga
Bristol Myers Squibb stock gains on positive arlocabtagene autoleucel trial results - AD HOC NEWS
Roivant surges on ‘exceptional’ results; Bristol Myers touts first-of-its-kind CAR-T therapy - Yahoo Finance
Bristol Myers' blood cancer cell therapy succeeds in mid-stage trial - Reuters
Bristol Myers' blood cancer cell therapy meets main goal in mid-stage trial - yahoo.com
Why Is Bristol Myers Squibb (NYSE:BMY) Under NYSE Focus Today? - Kalkine Media
Bristol Myers Squibb Company $BMY Shares Acquired by Amundi - MarketBeat
Bristol Myers Squibb stock heads into the open after a 1.9% slide - ad-hoc-news.de
Radioligand Therapy Market to Grow from USD 2.98 Billion in 2025 to USD 15.85 Billion by 2035, at a CAGR of 18.2% - GlobeNewswire Inc.
VIRGINIA RETIREMENT SYSTEMS ET Al Takes $99.23 Million Position in Bristol Myers Squibb Company $BMY - MarketBeat
Bristol-Myers Squibb (BMY): Investor Outlook with a Focus on Dividend Yield and Strategic Collaborations - DirectorsTalk Interviews
TD Waterhouse Canada Inc. Buys 53,881 Shares of Bristol Myers Squibb Company $BMY - MarketBeat
Why Davy thinks Bristol-Myers Squibb’s latest rally is one to cash in on - Business Post
Saudi Central Bank Purchases 67,780 Shares of Bristol Myers Squibb Company $BMY - MarketBeat
Bristol Myers Squibb Company $BMY Shares Sold by Mid American Wealth Advisory Group Inc. - MarketBeat
Bristol-Myers Squibb (NYSE:BMY) Flashes Strong Technical Breakout Setup - ChartMill
Munich Reinsurance Co Stock Corp in Munich Raises Stock Position in Bristol Myers Squibb Company $BMY - MarketBeat
Bristol Myers Squibb Company $BMY Shares Purchased by NEOS Investment Management LLC - MarketBeat
Bristol Myers Squibb Company $BMY Position Boosted by Concurrent Investment Advisors LLC - MarketBeat
Atopic Dermatitis Drugs Market Set to Reach USD 33.42 Billion by 2035, at a CAGR of 7.70% - GlobeNewswire Inc.
Why Bristol Myers Squibb (BMY) Dipped More Than Broader Market Today - Yahoo Finance
Bristol Myers Squibb Co. stock underperforms Friday when compared to competitors - MarketWatch
Will Long‑Term Camzyos Data and Real‑World Evidence Change Bristol Myers Squibb's (BMY) Narrative? - simplywall.st
Will Camzyos' Long-Term Benefits Strengthen BMY's Growth Outlook? - TradingView
Bristol-Myers Squibb stock steadies as CAR-T trial pause meets strong Q2 2026 figures - AD HOC NEWS
A Wall Street Analyst Spotted the Trial Freeze—Then Came News of Three Deaths - Benzinga
Bristol Myers Squibb: Still Cheap, Despite What The Chart Says (NYSE:BMY) - Seeking Alpha
Bristol Myers Squibb: Buy The Growth Portfolio At A Value Price (NYSE:BMY) - Seeking Alpha
Bristol Myers Squibb Company $BMY Shares Bought by Burford Brothers Inc. - MarketBeat
Bristol Myers Squibb stock gains on Q2 beat and raised 2026 guidance - AD HOC NEWS
Bristol-Myers Squibb Stock: Is BMY Outperforming the Healthcare Sector? - Barchart.com
Revisiting Stock Picks Dexcom, Bristol Myers Squibb, Quanta Services - Barron's
Bristol Myers Squibb stock gains on CAR-T pause and Camzyos momentum - AD HOC NEWS
Bristol Myers Squibb Co. stock underperforms Wednesday when compared to competitors despite daily gains - MarketWatch
Autoimmune CAR-T faces tough questions after Novartis, Bristol Myers study halts - BioPharma Dive
Cellares downsizes New Jersey operations after losing BMS cell therapy contract - fiercepharma.com
Stripped of AstraZeneca safety net, BMS could face ‘carnage’ if high-risk clinical trial fails - BioSpace
Bristol-Myers Squibb stock holds the mid-$60 range - AD HOC NEWS
Novartis, Bristol Myers pause autoimmune CAR-T trials due to safety concerns - BioPharma Dive
Quantitative Investment Management LLC Makes New Investment in Bristol Myers Squibb Company $BMY - MarketBeat
Wellington Management Group LLP Has $225.53 Million Holdings in Bristol Myers Squibb Company $BMY - MarketBeat
Benjamin Edwards Inc. Acquires 18,656 Shares of Bristol Myers Squibb Company $BMY - MarketBeat
Davidson Investment Advisors Sells 15,902 Shares of Bristol Myers Squibb Company $BMY - MarketBeat
Flputnam Investment Management Co. Purchases 26,360 Shares of Bristol Myers Squibb Company $BMY - MarketBeat
0.85%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):